| 摘要 |
<p>The present invention provides solid dosage formulations of [1,4]diazepino[6,7,1-ij]quinoline derivativesand processes for their manufacture. In some particular embodiments, the presentinvention provides novel formulations of the antipsychotic and antiobesityagent (9aR, 12aS)-4,5,6,7,9,9a,10,11,12,12a idecahydrocyclopenta[c][1,4]diazepino[6,7,1-ij]quinoline hydrochloride(Compound A-HCI).</p> |
